Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

9,282 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Belantamab mafodotin in combination with novel agents in relapsed/refractory multiple myeloma: DREAMM-5 study design.
Nooka AK, Weisel K, van de Donk NW, Routledge D, Otero PR, Song K, Quach H, Callander N, Minnema MC, Trudel S, Jackson NA, Ahlers CM, Im E, Cheng S, Smith L, Hareth N, Ferron-Brady G, Brouch M, de Oca RM, Paul S, Holkova B, Gupta I, Kremer BE, Richardson P. Nooka AK, et al. Among authors: cheng s. Future Oncol. 2021 Mar 8. doi: 10.2217/fon-2020-1269. Online ahead of print. Future Oncol. 2021. PMID: 33682447
Multicenter evaluation of four immunoassays for the performance of early diagnosis of COVID-19 and assessment of antibody responses of patients with pneumonia in Taiwan.
Lin YC, Lee YL, Cheng CY, Tseng WP, Wu JL, Lin CH, Chung MY, Kang CM, Lee YF, Chen CP, Huang CH, Liu CE, Cheng SH, Chen SC, Chen SY, Hsueh PR. Lin YC, et al. Among authors: cheng sh. J Microbiol Immunol Infect. 2021 Feb 23:S1684-1182(21)00046-3. doi: 10.1016/j.jmii.2021.02.003. Online ahead of print. J Microbiol Immunol Infect. 2021. PMID: 33676864
9,282 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page